Visitors and news

Breast cancer is the most common cancer among women worldwide, impacting 2.26 million women each year. Early detection through screening helps improve survival rates.
View the Breast Cancer Awareness Month 2021 IARC page to learn more about the global burden of breast cancer.

We organized this meeting for all principal investigators, programme managers, and key collaborators from the study sites involved in this project, to discuss the implementation and progress of the study.

Tiago Pinho Bandeira, medical resident in public health from Public Health Unit, Baixo Vouga Primary Healthcare Cluster (Aveiro, Portugal), has recently joined the Early Detection, Prevention, and Infections Branch (EPR). Tiago will be participated in research activities on monitoring and evaluating cancer screening programmes around the globe, evaluating data on measurable indicators and cancer screening participation, as well as inequalities in access to screening.

CanScreen5 collaborators from Latin America and the Caribbean have participated in the second live session on stakeholder analysis. They are working on identifying stakeholders to overcome barriers to cancer screening. This will feed the road map we will be working on in a face-to-face workshop in 2022.
View the project summary: Reducing inequalities in cancer screening: a case study in the Community of Caribbean and Latin American States (CELAC)

The CanScreen5 IARC Secretariat, following support of country collaborators and validation by our scientific committee, is happy to announce the availability on the CanScreen5 platform of the following country factsheets: Brazil, Canada (Quebec and Manitoba provinces data), Colombia, Guyana, Mexico, Panama, and Peru.
Visit the CanScreen5 website to explore characteristics and performance of cancer screening programmes across the globe in more than 60 countries

The CanScreen5 Train the Trainers learning programme has been presented to Latin American countries and will start this week. This will be the fourth training within the CanScreen5 project and so far 97 representatives from 39 countries have participated in a facilitated module blending online modules and live sessions. Thirty one countries have already submitted data on their cancer screening and it is being progressively uploaded on the CanScreen5 website after validation. The self-paced learning programme is publicly available in English and Russian, and under development in Spanish and French.

We initiated a study aiming to achieve an international consensus on the essential and desirable criteria that a cancer screening program needs to fulfill to be considered as ‘organized’. This study is a blend of systematic review and a Delphi consensus process, seeking opinions of the global experts in cancer screening. After two rounds of online survey with 24 internaional experts ’input, we organized an expert meeting, during which we presented the outcomes and focussed on the discussion on selected criteria with the experts.

The IARC is marking World Cancer Research Day by publishing a collection of visuals to highlight some of the Agency’s recent achievements in cancer research, as well as the researchers behind these achievements. In this poster, Dr Partha Basu, Deputy Head, Early Detection, Prevention, and Infections Branch, highlighted IARC’s research related to HPV vaccines, including a trial in India to evaluate whether a single dose of the vaccine is as protective as two doses and a phase III trial for an HPV vaccine produced in India, could greatly reduce the cost and increase the supply of available vaccines, expanding protection against HPV-associated cancers to more of the most vulnerable groups. Visit the IARC World Cancer Research Day webpage and view the poster

IARC scientists have held the virtual kick-off meeting of the Work package 6 of the H2020-GACD sponsored CBIG-SCREEN project. IARC is leading the WP6 that aims to pilot test the co-created tailored Cervical Cancer Screening Strategies in Estonia, Portugal and Romania. Discussions were held with collaborators around the preparatory work to do a capacity assessment of cervical cancer screening services in the three focus countries.

The International Agency for Research on Cancer (IARC) is participating in the CBIG-SCREEN project within the framework of the European Union Horizon2020 research and innovation programme. The CBIG-SCEEN project aims to reduce inequality by improving the offer of cervical cancer screening to vulnerable and underserved groups. Though Cervical Cancer Screening (CCS) programmes drastically reduce cervical cancer mortality, they remain largely inaccessible and underused by subpopulations of vulnerable women, exacerbating inequality. Though Cervical Cancer Screening (CCS) programmes drastically reduce cervical cancer mortality, they remain largely inaccessible and underused by subpopulations of vulnerable women, exacerbating inequality. Please visit http://cbig-screen.eu to find out more about cervical cancer screening and how to tackle inequalities